S417L (p.Ser417Leu) variant of TRAF3IP2 (E3 ubiquitin ligase TRAF3IP2)
S417L (p.Ser417Leu) in TRAF3IP2 (E3 ubiquitin ligase TRAF3IP2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.44 / 1. The record also includes population frequency data and structural context.
S417L (p.Ser417Leu) variant details
- p.Ser417Leu
- rs1419307347
- NCI-TCGA Cosmic COSV1003
- cosmic curated COSV10038
- NCI-TCGA Cosmic COSV6067
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.441
- AlphaMissense 0.99
- MetaLR 0.19
- MetaSVM -0.79
- PolyPhen-2 1.00
- SIFT 0.00
- EVE 0.64
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available